The SUNY Distinguished Professor is the recipient of the 2020 Distinguished Pharmaceutical Scientist Award from the American Association of Pharmaceutical Sciences.
When a corporation’s earnings are steady, its board of directors is more likely to fire its CEO after a bad earnings period, new UB research has found.
UB spinoff Cytocybernetics is developing a tool to rapidly assess if investigational COVID-19 drugs have properties that can result in sudden cardiac death.
Engineering faculty Paul DesJardin and Joseph Mollendorf are part of an Ohio State project to reduce air pollution and raise the efficiency of the popular devices.
Research led by UB faculty member Jonathan Lovell suggests that transforming a coronavirus protein into a nanoparticle could potentially neutralize the virus.